Pharmaceuticals for the treatment of neurodegenerative disease, genetic disorder, neuromuscular disease, alzheimer's disease, parkinson's disease, huntington's disease, amyotrophic lateral sclerosis, muscle disorder, or immune related disorder; drug delivery agents in the form of capsules, granules, liquids, transdermal systems(patches), pellets, pills, powders, solutions, suspensions or tablets that facilitate the delivery of pharmaceutical preparations; medicated skin care preparations

Medical laboratories; clinical research in the field of medicine for the treatment of neurodegenerative disease, genetic disorder, neuromuscular disease, alzheimer's disease, parkinson's disease, huntington's disease, amyotrophic lateral sclerosis, muscle disorder, or immune related disorder